Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (N...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Qiao, B, Kerr, M, Groselj, B, Teo, M, Knowles, M, Bristow, R, Phillips, R, Kiltie, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2013

Míreanna comhchosúla

Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity.
de réir: Choudhury, A, et al.
Foilsithe / Cruthaithe: (2009)

E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
de réir: Nicholson, J, et al.
Foilsithe / Cruthaithe: (2017)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2013)

The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2012)

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity
de réir: Benjamin C. Chandler, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51.
de réir: Qiao Liu, et al.
Foilsithe / Cruthaithe: (2011-01-01)

RAD51: A DNA repair target for increasing the therapeutic potential in bladder cancer
de réir: Choudhury, A, et al.
Foilsithe / Cruthaithe: (2005)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
de réir: Kerr, M, et al.
Foilsithe / Cruthaithe: (2012)

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
de réir: Xin Zhang, et al.
Foilsithe / Cruthaithe: (2017-09-01)

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
de réir: Weigel Marion T, et al.
Foilsithe / Cruthaithe: (2010-08-01)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
de réir: Kerr, M, et al.
Foilsithe / Cruthaithe: (2012)

Three-in-One Nanozyme for Radiosensitization of Bladder Cancer
de réir: Li Y, et al.
Foilsithe / Cruthaithe: (2024-10-01)

IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
de réir: Chitnis, M, et al.
Foilsithe / Cruthaithe: (2014)

Radiosensitation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2017)

Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency
de réir: Tim Heemskerk, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
de réir: Manish Kumar, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Selective targeting of homologous recombination deficiency
de réir: Zimmer, J
Foilsithe / Cruthaithe: (2014)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
de réir: Genevieve Dall, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Analysis of variants in DNA damage signalling genes in bladder cancer
de réir: Choudhury, A, et al.
Foilsithe / Cruthaithe: (2008)

Targeting acid ceramidase to improve the radiosensitivity of rectal cancer
de réir: Clifford, R, et al.
Foilsithe / Cruthaithe: (2020)

Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts.
de réir: Diggle, C, et al.
Foilsithe / Cruthaithe: (2005)

In vitro functional effects of XPC gene rare variants from bladder cancer patients.
de réir: Qiao, B, et al.
Foilsithe / Cruthaithe: (2011)

P53 gene targeting by homologous recombination in fish ES cells
de réir: Yan, Yan, et al.
Foilsithe / Cruthaithe: (2013)

p53 gene targeting by homologous recombination in fish ES cells.
de réir: Yan Yan, et al.
Foilsithe / Cruthaithe: (2013-01-01)

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
de réir: Choudhury, A, et al.
Foilsithe / Cruthaithe: (2010)

Assessment of acute bowel toxicity from chemoradiation for bladder cancer using an in vivo gastrointestinal crypt assay and in vitro organoid system
de réir: Gorrill, J, et al.
Foilsithe / Cruthaithe: (2017)

Targeting the organelle for radiosensitization in cancer radiotherapy
de réir: Xiaoyan Sun, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2013)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
de réir: Groselj, B, et al.
Foilsithe / Cruthaithe: (2013)

Fibroblast radiosensitivity measured using the comet assay correlates with clonogenic survival parameters
de réir: Eastham, A, et al.
Foilsithe / Cruthaithe: (1999)

BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
de réir: Yangyang Kong, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Homologous Recombination Assay
de réir: Yvan Canitrot, et al.
Foilsithe / Cruthaithe: (2013-09-01)

The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
de réir: Groselj, B
Foilsithe / Cruthaithe: (2014)

Homologous recombination proficiency in ovarian and breast cancer patients
de réir: Justin Fortune Creeden, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Targeted recombination of homologous chromosomes using CRISPR‐Cas9
de réir: Wonseok Son, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Targeted recombination between homologous chromosomes for precise breeding in tomato
de réir: Shdema Filler Hayut, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
de réir: Qiao, B, et al.
Foilsithe / Cruthaithe: (2011)

USP4 auto-deubiquitylation promotes homologous recombination
de réir: Wijnhoven, P, et al.
Foilsithe / Cruthaithe: (2015)

DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining.
de réir: Bentley, J, et al.
Foilsithe / Cruthaithe: (2004)